EN

Platform Innovation
Business Unit

Our Platform Innovation Business Unit offers a diverse range of services to support research and development in regenerative medicine, pharmaceuticals, culture equipment, and related technologies using induced pluripotent stem (iPS) cells. By combining our advanced cell differentiation, analysis, and manufacturing technologies, we deliver flexible and high-quality solutions tailored to the specific needs and stages of your research. Whether you're exploring early-stage concepts or advancing toward commercialization, we’re here to help accelerate your progress. Contact us today to discuss how we can support your innovation.

Contract
Research ServicesConsulting ServicesOn-site Support
Services

Process Flow

  1. Inquiry

    Please feel free to contact us anytime ( )

  2. Confidential Disclosure Agreement (CDA)

    We will enter into CDA upon request and discuss your project details confidentially.

  3. Confirmation of Service Details

    We conduct a detailed interview to understand your desired tasks and specifications.

  4. Provision of Preliminary Quotation

    Based on the interview, we will provide an estimated quotation.

  5. Contract Conclusion

    After finalizing the scope of work and contract terms, we will formally conclude the outsourcing agreement.

  6. Execution of Work

    Our team will proceed carefully and reliably according to the contract.

  7. Delivery and Billing

    Upon delivery of results, we will issue an invoice and complete the necessary procedures.

Please feel free to contact us at any time.

Contract Research Services

Orizuru Therapeutics, Platform Innovation Business Unit provides contract research services to support diverse iPS cell research activities. We are committed to delivering flexible, high-quality solutions tailored to your needs. Please do not hesitate to contact us.

Our Contract Research Services Include:

  1. iPS Cell Related Services
    1. Differentiation Culture and Pharmacological Evaluation of iPS Cells
      1. Differentiation Culture

        Based on protocols provided by our clients, we perform differentiation of iPS cells and generate cell spheroids and organoids. In addition, we conduct pharmacological evaluations using these differentiated cells.

      2. Optimization of Differentiation Conditions

        We explore and establish optimal conditions to obtain the target cell type as requested by our clients.

      3. Reproduction of Published Protocols

        We perform replication studies based on published protocols to reproduce reported differentiation procedures.

      4. Other Services

        We are happy to flexibly accommodate other requests according to your specific needs.

    2. Additional Support Services

      We also offer flexible support for other culture-related needs, including consulting and optimization for process development aimed at commercial use—one of our core strengths—as well as support for stable maintenance culture of undifferentiated iPS cells.

  2. Supply of iPS Cell-Derived Research Cells
    1. iPS cell-derived pancreatic islet cell for research purposes: under development.
    2. iPS cell-derived cardiomyocytes for research purposes: under development.

      We will manufacture cells using some of our proprietary expertise developed through our clinical pipeline of iPSC-derived pancreatic islet cells and cardiomyocytes.

      If you are interested, please feel free to contact us.

  3. Cellular Function Analysis Services
    1. Pluripotency assessment (flow cytometry, imaging)
    2. Marker analysis post-differentiation (flow cytometry, imaging, qPCR, ELISA)
    3. Electrophysiological evaluation (MEA method)
    4. Immune response and rejection evaluation (MLR method)
    5. Flexible support for other analysis requests

Consulting Services

Our consulting services offer expert investigations and analyses to help resolve technical challenges in iPS cell research.

On-site Support Services

Our staff can visit your laboratory to provide direct technical assistance. This service is ideal for temporary staffing shortages or when onsite expertise is needed.
Please note: This service is offered under a service outsourcing contract for specific tasks, not as labor dispatch.

Contact Information

Orizuru Therapeutics, Inc.
Platform Innovation Business Unit
Email:
Address: 2-26-1 Muraoka-Higashi, Fujisawa-shi, Kanagawa 251-8555, Japan